All Images
News Release 05-011
Nanoscale Diagnostic Sets Sights on Alzheimer's
Experimental procedure detects possible traces of disease in cerebrospinal fluid
This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.
The bio-bar-code amplification technology, which is a million times more sensitive than enzyme-linked immunoassay (ELISA) tests, can detect ADDLs in cerebrospinal fluid where the biomarker is present in very low concentrations. The goal is to ultimately detect and validate the marker in blood.
Credit: Northwestern University
Download the high-resolution TIF version of the image. (113 KB)
Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.